C4 Therapeutics (CCCC) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
C4 Therapeutics (CCCC) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 0.15 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -0.06 |
| 10 | C4 Therapeutics | 495.99 Mn | 242.33 Mn | - | -0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.25 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -0.37 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.26 |
| Mar 31, 2024 | -0.41 |
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.73 |
| Mar 31, 2023 | -0.71 |
| Dec 31, 2022 | -0.76 |
| Sep 30, 2022 | -0.65 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -0.51 |